Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization

Some studies have shown that sorafenib could significantly prolong the overall survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization (TACE). However, other studies revealed that patients had no access to sorafenib-related survival benef...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Kun, Yang, Zelong, Liu, Xinyu, Yang, Yanling, Song, Wenjie, Wang, Shangyu, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857819/
https://www.ncbi.nlm.nih.gov/pubmed/36661687
http://dx.doi.org/10.3390/curroncol30010038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857819/
https://www.ncbi.nlm.nih.gov/pubmed/36661687
http://dx.doi.org/10.3390/curroncol30010038

Ejemplares similares